Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans. 1985

J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis

The pharmacokinetics of cefonicid were investigated in eight healthy adults. A one-gram dose was administered either intramuscularly or intravenously in a cross-over design study. Mean peak cefonicid plasma concentrations of 186 to 204 mcg/ml and 88 to 123 mcg/ml were achieved after intravenous and intramuscular injection, respectively, with elimination half-lives of 4.9 h and 5.3 h. Cefonicid concentrations were measured by both microbiological (M.A.) and high-performance liquid chromatography (HPLC) assays. Results were quite similar with the two techniques, except for the urinary recovery of cefonicid in the first 24 hours (83% of the dose with MA - vs 53% with HPLC method). The apparent volume of distribution (Vd area) was 0.18 1/kg; the total body clearance (CT) and the renal clearance (CR) were 24-26 ml/min and 15-19 ml/min, respectively. The kinetic data of cefonicid were not significantly different for the two routes of administration. A one-gram i.v. or i.m. cefonicid dose produced high and prolonged plasma concentrations with a longer half-life than obtained with commonly used cephalosporins.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D015790 Cefonicid A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. Cefonicid Disodium Salt,Cefonicid Monosodium,Cefonicid Monosodium Salt,Monocid,SK&F-75073,SKF-75073-2,Sodium Cefonicid,Cefonicid, Sodium,SK&F 75073,SK&F75073,SKF 75073 2,SKF750732

Related Publications

J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
November 1983, Antimicrobial agents and chemotherapy,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
October 1984, Antimicrobial agents and chemotherapy,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
October 1985, Antimicrobial agents and chemotherapy,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
April 1992, The Journal of antimicrobial chemotherapy,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
March 1990, Research in veterinary science,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
October 1998, Journal of the American Veterinary Medical Association,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
April 1988, American journal of veterinary research,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
August 1999, Journal of veterinary pharmacology and therapeutics,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
January 1996, The American journal of clinical nutrition,
J B Fourtillan, and A Leroy, and M A Lefebvre, and G Humbert, and J P Fillastre, and G Reumont, and N Ramis
January 1987, Infection,
Copied contents to your clipboard!